The Food and Drug Administration yesterday updated health care providers about a type of lymphoma associated with breast implants and recommendations to inform patients about the risk and report, evaluate and treat the condition. Providers, patients and manufacturers have reported 457 cases of breast implant-associated anaplastic large cell lymphoma since 2010, including nine deaths. For more information, visit www.fda.gov.

Related News Articles

Headline
The National Institutes of Health yesterday awarded grants to five new projects through its Health Care Systems Research Collaboratory, which conducts clinical…
Insights and Analysis
Lawrence General Hospital Targets Food Insecurity Where It Counts  With social factors influencing up to 80 percent of health outcomes, hospitals are…
Insights and Analysis
Even as a nurse, married to a physician, I found helping my aging parents navigate the health care labyrinth to be a daunting and eye-opening experience. My…
Blog
We previously raised concerns about the most recent “The Price Ain’t Right” study by a group of academic economists that attempted to link hospital…
Headline
The House last night voted 230 to 185 to approve the Standard Merger and Acquisition Reviews Through Equal Rules Act (H.R. 5645), AHA-supported legislation…
Insights and Analysis
As changing clinical roles and technical innovations require care coordination to be approached as a team sport, it’s important to encourage provider…